Physician profile
Janet E Gaston
NPI 1053351825
$479.32
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $113.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $147.48 | 2019-2020 | |
| Adlon Therapeutics L.P. | $79.89 | 2019 | |
| Pfizer INC. | $52.44 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $45.06 | 2019 | |
| Merck Sharp & Dohme LLC | $31.61 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.96 | 2019 | |
| Hologic Sales and Service, LLC | $21.05 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.94 | 2020 | |
| Allergan, INC. | $18.02 | 2020 | |
| Sanofi Pasteur INC. | $14.06 | 2019 | |
| Bausch Health US, LLC | $13.86 | 2019 | |
| Kaleo, INC. | $10.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Gaston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.